Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries

Kwangwoo Kim, Elizabeth E. Brown, Chan Bum Choi, Marta E. Alarcón-Riquelme, Jennifer A. Kelly, Stuart B. Glenn, Joshua O. Ojwang, Adam Adler, Hye Soon Lee, Susan A. Boackle, Lindsey A. Criswell, Graciela S. Alarcón, Jeffrey C. Edberg, Anne M. Stevens, Chaim O. Jacob, Gary S. Gilkeson, Diane L. Kamen, Betty P. Tsao, Juan Manuel Anaya, Joel M. GuthridgeSwapan K. Nath, Bruce Richardson, Amr H. Sawalha, Young Mo Kang, Seung Cheol Shim, Chang Hee Suh, Soo Kon Lee, Chang Sik Kim, Joan T. Merrill, Michelle Petri, Rosalind Ramsey-Goldman, Luis M. Vil, Timothy B. Niewold, Javier Martin, Bernardo A. Pons-Estel, Timothy J. Vyse, Barry I. Freedman, Kathy L. Moser, Patrick M. Gaffney, Adrienne Williams, Mary Comeau, John D. Reveille, Judith A. James, R. Hal Scofield, Carl D. Langefeld, Kenneth M. Kaufman, John B. Harley, Changwon Kang*, Robert P. Kimberly, Sang Cheol Bae

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

57 Scopus citations


Objective: Systemic lupus erythematosus (SLE; OMIM 152700) is a chronic autoimmune disease for which the aetiology includes genetic and environmental factors. ITGAM, integrin αM(complement component 3 receptor 3 subunit) encoding a ligand for intracellular adhesion molecule (ICAM) proteins, is an established SLE susceptibility locus. This study aimed to evaluate the independent and joint effects of genetic variations in the genes that encode ITGAM and ICAM. Methods: The authors examined several markers in the ICAM1-ICAM4-ICAM5 locus on chromosome 19p13 and the single ITGAM polymorphism (rs1143679) using a large-scale case-control study of 17 481 unrelated participants from four ancestry populations. The singlemarker association and gene-gene interaction were analysed for each ancestry, and a meta-analysis across the four ancestries was performed. Results: The A-allele of ICAM1-ICAM4-ICAM5 rs3093030, associated with elevated plasma levels of soluble ICAM1, and the A-allele of ITGAM rs1143679 showed the strongest association with increased SLE susceptibility in each of the ancestry populations and the trans-ancestry meta-analysis (ORmeta=1.16, 95% CI 1.11 to 1.22; p=4.88 × 10-10 and ORmeta=1.67, 95% CI 1.55 to 1.79; p=3.32 × 10-46, respectively). The effect of the ICAM single-nucleotide polymorphisms (SNPs) was independent of the effect of the ITGAM SNP rs1143679, and carriers of both ICAM rs3093030-AA and ITGAM rs1143679-AA had an OR of 4.08 compared with those with no risk allele in either SNP (95% CI 2.09 to 7.98; p=3.91 × 10-5). Conclusion: These findings are the first to suggest that an ICAM-integrin-mediated pathway contributes to susceptibility to SLE.

Original languageEnglish (US)
Pages (from-to)1809-1814
Number of pages6
JournalAnnals of the rheumatic diseases
Issue number11
StatePublished - Nov 2012

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology
  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries'. Together they form a unique fingerprint.

Cite this